Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

6 May 2021 15:06

RNS Number : 8269X
Cenkos Securities PLC
06 May 2021
 

6 May 2021

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

 

Further to the announcement released on 9 December 2020 relating to the retirement of Jim Durkin, Chief Executive Officer, at the forthcoming Annual General Meeting, and the appointment of Julian Morse as the new Chief Executive Officer, the Board is pleased to confirm that Julian's appointment has now received regulatory approval from the Financial Conduct Authority. Julian will be appointed to the position of Chief Executive Officer which will take place immediately following the Company's Annual General Meeting on 12 May 2021.

 

The Board is also pleased to announce that Jeremy Osler's appointment as an Executive Director of the Company, has also received regulatory approval from the Financial Conduct Authority. Jeremy will join the Board immediately following the Company's Annual General Meeting on 12 May 2021.

 

Commenting on the Board changes, Lisa Gordon Non-Executive Chairman said:

 

"On behalf of the Board I would like to pay tribute to Jim Durkin, who has been central to the creation and development of Cenkos over the past 16 years. I have hugely enjoyed working with Jim over the last 12 months on the blueprint for Cenkos' ongoing success and we wish him well in his forthcoming retirement.

 

The appointment of Julian Morse as Chief Executive Officer and wider changes to the senior management team across the Firm, including the appointment of Jeremy Osler to the Board as Executive Director, creates a strong team to lead and take the business forward." 

 

For further information, please contact:

Cenkos Securities plc

Lisa Gordon, Non-Executive Chairman

Julian Morse, Executive Director Tel: 0207 397 8900

 

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser Tel: 0203 368 3552

 

The Nisse Consultancy - Public relations

Jason Nisse Tel: 07769 688618

Andrew Garfield Tel: 07974 982337

 

 

Additional Information 

The only change to the information previously supplied on 9 December 2020 in respect of Jeremy Osler's appointment as required under Schedule 2(g) of the AIM Rules is that his current interest in the Company's share capital is now made up of:  

 

49,627 Ordinary shares held in an ordinary managed account.

93,470 Ordinary shares held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares held in the Company's Share Incentive Plan.

Option over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

Option over 40,000 Ordinary shares held under the Company's Share Option Plan. These options are at 73.50 pence, subject to a performance condition, and vest in April 2024.

A nil cost Option over 510,000 Ordinary shares held under the Company's Long Term Incentive Plan. These options are subject to a performance condition and vest equally in April 2024, 2025 and 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAFMITMTMMBJB
Date   Source Headline
30th Nov 20228:54 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 202210:39 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20229:45 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20228:51 amRNSForm 8.5 (EPT/NON-RI)
17th Nov 20229:16 amRNSForm 8.5 (EPT/NON-RI)
16th Nov 20229:03 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
15th Nov 20229:32 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20228:55 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 20229:13 amRNSForm 8.5 (EPT/NON-RI)
4th Nov 202211:33 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
4th Nov 202211:31 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
3rd Nov 202210:23 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
3rd Nov 202210:21 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202211:08 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202211:00 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20229:33 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20229:25 amRNSForm 8.5 (EPT/NON-RI)
31st Oct 20229:25 amRNSForm 8.5 (EPT/NON-RI)
27th Oct 20227:00 amRNSBlock listing Interim Review
26th Oct 20229:23 amRNSForm 8.5 (EPT/NON-RI)
21st Oct 20228:43 amRNSForm 8.5 (EPT/NON-RI)
20th Oct 20229:05 amRNSForm 8.5 (EPT/NON-RI)
19th Oct 20229:37 amRNSForm 8.5 (EPT/NON-RI)
18th Oct 202210:16 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
5th Oct 20224:40 pmRNSSecond Price Monitoring Extn
5th Oct 20224:35 pmRNSPrice Monitoring Extension
16th Sep 20227:01 amEQSCenkos Securities (CNKS): Flexible model well suited to market conditions
8th Sep 20224:47 pmRNSRevision of the EBT Share Purchase Plan
8th Sep 20227:00 amRNSInterim Results for the 6mths Ended 30 June 2022
16th May 20226:01 pmRNSPDMR Dealings
11th May 20224:33 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
4th May 20228:45 amRNSBlock Admission Interim Review
20th Apr 20223:34 pmRNSPDMR Dealings
8th Apr 20224:25 pmRNSDirector and PDMR Shareholdings - Grant of Awards
8th Apr 20221:25 pmRNSForm 8.5 (EPT/NON-RI)
7th Apr 20224:59 pmRNSPDMR Shareholdings and LTIP Awards
7th Apr 20224:56 pmRNSPDMR Shareholding
7th Apr 20229:50 amRNSForm 8.5 (EPT/NON-RI)
6th Apr 20229:17 amRNSForm 8.5 (EPT/NON-RI)
4th Apr 202210:14 amRNSPosting of Annual Report and AGM Notice
30th Mar 20229:45 amRNSForm 8.5 (EPT/NON-RI) - Sound Energy PLC
29th Mar 202211:22 amRNSForm 8.5 (EPT/NON-RI)
22nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20229:48 amRNSDirector Shareholding
18th Mar 20228:35 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 20227:00 amRNSAnnual Results for the year ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.